Literature DB >> 31663645

MicroRNA profiles of MS gray matter lesions identify modulators of the synaptic protein synaptotagmin-7.

Lena Fritsche1, Sarah Teuber-Hanselmann1, Daniel Soub1, Kim Harnisch1, Fabian Mairinger2, Andreas Junker1.   

Abstract

We established microRNA (miRNA) profiles in gray and white matter multiple sclerosis (MS) lesions and identified seven miRNAs which were significantly more upregulated in the gray matter lesions. Five of those seven miRNAs, miR-330-3p, miR-4286, miR-4488, let-7e-5p, miR-432-5p shared the common target synaptotagmin7 (Syt7). Immunohistochemistry and transcript analyses using nanostring technology revealed a maldistribution of Syt7, with Syt7 accumulation in neuronal soma and decreased expression in axonal structures. This maldistribution could be at least partially explained by an axonal Syt7 transport disturbance. Since Syt7 is a synapse-associated molecule, this maldistribution could result in impairment of neuronal functions in MS patients. Thus, our results lead to the hypothesis that the overexpression of these five miRNAs in gray matter lesions is a cellular mechanism to reduce further endogenous neuronal Syt7 production. Therefore, miRNAs seem to play an important role as modulators of neuronal structures in MS.
© 2019 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Entities:  

Keywords:  Synaptotagmin7; axonal transport disturbance; gray matter lesions; miRNA profiling; microRNA; multiple sclerosis

Mesh:

Substances:

Year:  2019        PMID: 31663645     DOI: 10.1111/bpa.12800

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  7 in total

Review 1.  Imprinted Genes and Multiple Sclerosis: What Do We Know?

Authors:  Natalia Baulina; Ivan Kiselev; Olga Favorova
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

Review 2.  miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology.

Authors:  Alexander D Walsh; Linda T Nguyen; Michele D Binder
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 5.200

3.  Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology.

Authors:  Galina Yurevna Zheleznyakova; Eliane Piket; Maria Needhamsen; Michael Hagemann-Jensen; Diana Ekman; Yanan Han; Tojo James; Mohsen Khademi; Faiez Al Nimer; Patrick Scicluna; Jesse Huang; Ingrid Kockum; Omid R Faridani; Tomas Olsson; Fredrik Piehl; Maja Jagodic
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

4.  MGMT-Methylation in Non-Neoplastic Diseases of the Central Nervous System.

Authors:  Sarah Teuber-Hanselmann; Karl Worm; Nicole Macha; Andreas Junker
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

5.  Identifying miRNAs in multiple sclerosis gray matter lesions that correlate with atrophy measures.

Authors:  Ajai Tripathi; Ishani Pandit; Aaron Perles; Yadi Zhou; Feixiong Cheng; Ranjan Dutta
Journal:  Ann Clin Transl Neurol       Date:  2021-05-12       Impact factor: 4.511

6.  A Systematic Review of Tissue and Single Cell Transcriptome/Proteome Studies of the Brain in Multiple Sclerosis.

Authors:  Maria L Elkjaer; Richard Röttger; Jan Baumbach; Zsolt Illes
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

Review 7.  Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations.

Authors:  Tamás Biernacki; Zsófia Kokas; Dániel Sandi; Judit Füvesi; Zsanett Fricska-Nagy; Péter Faragó; Tamás Zsigmond Kincses; Péter Klivényi; Krisztina Bencsik; László Vécsei
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.